Do Not Combine Zaleplon and Temazepam
You should not give zaleplon (Sonata) and temazepam (Restoril) together. Both are sedative-hypnotics that act on GABA receptors and combining them significantly increases the risk of excessive CNS depression, respiratory depression, oversedation, falls, and complex sleep behaviors.
Why This Combination Is Dangerous
Overlapping Mechanisms and Additive CNS Depression
Both medications work through GABAergic mechanisms:
- Zaleplon: Non-benzodiazepine hypnotic (Z-drug) that binds preferentially to α1β2γ2 GABA-A receptor subunits 1
- Temazepam: Benzodiazepine that acts on GABA-A receptors
The FDA label for Restoril explicitly warns: "If Restoril is to be combined with other drugs having known hypnotic properties or CNS-depressant effects, consideration should be given to potential additive effects" 2. This is not a suggestion to proceed cautiously—it's a warning that additive effects are expected and dangerous.
Specific Risks of Combination
The combination creates compounded risks:
- Excessive sedation and respiratory depression: Both drugs depress CNS function; combining them multiplies this effect
- Increased fall risk: Particularly dangerous in elderly patients, where temazepam alone already carries fall risk 3
- Complex sleep behaviors: "Sleep-driving" and other dangerous behaviors are more likely when Restoril is combined with other CNS depressants 2
- Cognitive and psychomotor impairment: Prolonged next-day effects become more likely
- Synergistic toxicity: The FDA label specifically mentions synergistic effects with other sedatives 2
The Correct Approach: Choose One Agent
Selection Algorithm
For sleep-onset insomnia only:
- Use zaleplon 10 mg (ultra-short half-life ~1 hour, minimal next-day effects) 4, 1
- Alternative: temazepam 15 mg 4
For sleep-maintenance insomnia:
- Use temazepam 15 mg (longer duration of action) 4, 5
- Zaleplon is less effective for maintenance due to its short half-life 1
For both sleep-onset AND maintenance:
- Use temazepam 15 mg as single agent 4
- Do NOT add zaleplon to extend coverage
Evidence Supporting Single-Agent Therapy
The 2017 American Academy of Sleep Medicine guidelines recommend these agents as monotherapy alternatives, not as combination therapy 4. A direct comparison study showed temazepam provided "significantly longer and qualitatively better sleep than zaleplon" when each was used alone 5.
Common Pitfalls to Avoid
- Don't layer hypnotics: If one agent isn't working, switch to a different class (e.g., orexin antagonist, low-dose doxepin), don't add another GABA-ergic agent
- Don't assume "different classes" means safe combination: Z-drugs and benzodiazepines both work through GABA mechanisms
- Elderly patients are at highest risk: The combination dramatically increases fall risk, confusion, and oversedation in this population 2, 3
- Middle-of-night dosing concerns: Even if considering zaleplon for middle-of-night awakening while on temazepam—don't do it; the drugs will overlap
What to Do Instead
If a single hypnotic is inadequate:
- First: Optimize the current agent's dose and timing
- Second: Switch to a different mechanism (suvorexant, low-dose doxepin, ramelteon)
- Third: Address underlying causes (sleep hygiene, cognitive behavioral therapy for insomnia)
- Never: Combine two GABA-ergic hypnotics
The evidence is clear: these medications should be used as monotherapy alternatives, not in combination. The risk of serious adverse events—including potentially fatal respiratory depression—far outweighs any theoretical benefit of combining them.